Zobrazeno 1 - 10
of 33
pro vyhledávání: '"Andre Mattar"'
Autor:
Marcelo Antonini, Gabriel Duque Pannain, Gabriela Silva Solino de Souza, Odair Ferraro, Andre Mattar, Reginaldo Guedes Coelho Lopes, Juliana Monte Real
Publikováno v:
Einstein (São Paulo), Vol 22 (2024)
ABSTRACT Objective: To evaluate the knowledge and practices of gynecologists, obstetricians, and family and community physicians in Brazil regarding breast cancer screening, mammographic findings defined by the BIRADS™ system, and their approach to
Externí odkaz:
https://doaj.org/article/4bc440d866444e78900ec07aab925583
Autor:
Marcelo Antonini, Denise J.P. da C. Pinheiro, Ana B.T. de M.B. Matos, Odair Ferraro, Andre Mattar, Lucas M. Okumura, Reginaldo G.C. Lopes, Juliana M. Real
Publikováno v:
Preventive Medicine Reports, Vol 32, Iss , Pp 102157- (2023)
During the COVID-19 pandemic, several screening exams were postponed, including mammograms. The aim of this study was to evaluate the impact of COVID-19 in mammographic screening in Brazil, considering 2015 to 2021. This was descriptive ecologic stud
Externí odkaz:
https://doaj.org/article/58108ae85f5f422db642d9f66cde417c
Publikováno v:
Cancer Research. 83:P1-04
Background: HER2 is a tyrosine kinase receptor belonging to the human epidermal receptor family and is considered an important proto-oncogene in the biology of breast carcinoma. HER2 overexpression is determined by a +3 score on the immunohistochemis
Autor:
Marcellus Ramos, Andre Mattar, Andressa Amorim, Felipe Cavagna, Mariana Passos, Raquel Fernandes, Jorge Shida, Luiz Henrique Gebrim
Publikováno v:
Cancer Research. 83:P4-07
Background Ductal carcinoma-in-situ (DCIS) is a growing health problem in the world. Before the advent of screening mammography, the incidence of DCIS was low, and patients presented with DCIS that had become clinically symptomatic. Upon this evidenc
Autor:
MARCELO ANTONINI, AMANDA LEAL GUIMARAES, FERNANDA GRACE BAUk RICHTER, ODAIR FERRARO, REGINALDO G. COELHO LOPES, JULIANA M. REAL, ANDRE MATTAR
Publikováno v:
Cancer Research. 83:P3-05
Introduction: Metabolic syndrome can be defined as a set of conditions - central obesity (waist circumference), elevated blood pressure, reduced HDL cholesterol, increased triglycerides and glucose intolerance - which is known to be associated with a
Autor:
Marina Diogenes, ANDRE MATTAR, Andressa Amorim, Maria Isabela Caldas Sawada, Luiz Henrique Gebrim, Jorge Shida
Publikováno v:
Cancer Research. 83:P3-05
Background: The evaluation of regional lymph nodes in patients with breast cancer is one of the main predictive and prognostic factors for treatment. The most frequently methods of percutaneous evaluation for suspicious lymph nodes are fine needle as
Autor:
MARCELO ANTONINI, BARROS T. TAIS, JULIANA M. REAL, REGINALDO G. COELHO LOPES, ODAIR FERRARO, ANDRE MATTAR, LUCAS OKUMURA
Publikováno v:
Cancer Research. 83:P3-05
Objective: Pregnancy-associated breast cancer (PABC) is defined as diagnosed during pregnancy or within one year of childbirth, in which current evidence associates with poor prognosis, without showing what clinical characteristics could impact in su
Autor:
FERNANDA GRACE BAUk RICHTER, ANDRE MATTAR, Marcelo Antonini, REGINALDO G. COELHO LOPES, Jorge Y. Shida, Luis Henrique Gebrim, Juliana Monte Real
Publikováno v:
Cancer Research. 83:P3-05
Introduction Breast cancer (BC) it is highly prevalent in the world with a significant mortality rate despite advances in systemic therapies. Obesity increases the risk of this cancer specially in post-menopause women and may even affect the prognosi
Autor:
Marcelo Antonini, Gisela RosaFranco Salerno, Natalia DanielaKovalinski Vieira, Mariana Soares Cardoso, Matheus de Paula Solino, Raissa Naiarade Barros Vasconcelos, Lais de Albuquerque Vasconcelos, Odair Ferraro, Andre Mattar, Reginaldo GuedesCoelho Lopes, Juliana Monte Real
Publikováno v:
Cancer Research. 82:P1-13
Introduction: Breast cancer is the most common among women worldwide. Approximately 67% of women with breast cancer are hormone receptor (RH) positive, so adjuvant endocrine therapy is often used. However, the impact of aromatase inhibitors on mainta
Publikováno v:
Cancer Research. 83:P3-03
Background Breast cancer (BC) continues to be highly prevalent and lethal among women worldwide. Obesity is an established risk factor for several types of cancer, including BC, particularly in postmenopausal women. Obesity may also be a prognostic f